| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |